17 Feb 2025
Analysis Alligator: Promising results from partner
21 May 2019
Alligator’s partner for the ADC-1013-project has revealed long-awaited trial results. Strong early efficacy results for the CD40-class of immuno-oncology drugs in pancreatic cancer have also emerged recently, underlining opportunites. Increased clinical activity could generate value-driving news flow.
Read the full report (Swedish) here.